Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

testosterone/rak

Veza se sprema u međuspremnik
Stranica 1 iz 41 rezultatima

Prophylactic perioperative testosterone supplementation for protection of and recovery of function

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
U.S. GOVERNMENT SUPPORT Not applicable. BACKGROUND OF THE INVENTION 1. Area of the Background This invention is generally in the area of urology and more specifically in improved treatment and outcome for radical prostatectomy surgery. 2. Description of the Background Low testosterone level

Pharmaceutical compositions containing testosterone and an aromatase inhibitor

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND Testosterone, delivered by subcutaneous pellet implant has been used in the United States, Europe and Australia in both men and women to treat symptoms of testosterone deficiency. Symptoms of testosterone hormone deficiency include fatigue, lack of energy, depression, memory loss,
BACKGROUND OF THE INVENTION A. Field of the Invention The invention relates to the use of nutrient combinations to prevent or reduce potential adverse effects from administration of androgenic testosterone precursors to humans and other mammals Specifically, the invention relates to

Methods for decreasing steroidogenesis in prostate cancer cells

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION The present invention relates in general to compositions and methods for treatment of cancer. More specifically, the invention provides compositions and methods for treating diseases such as cancer by disrupting the luteinizing hormone (LH)/luteinizing hormone receptor (LHR)

Method of treating prostate cancer with GnRH antagonist

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Prostate cancer is a leading cause of morbidity and mortality for men in the industrialized world. The American Cancer Society estimates that during 2007 about 218,890 new cases of prostate cancer will have been diagnosed in the United States alone. Prostate cancer is the second leading cause of

Method of treating prostate cancer with GnRH antagonist

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Prostate cancer is a leading cause of morbidity and mortality for men in the industrialized world. The American Cancer Society estimates that during 2007 about 218,890 new cases of prostate cancer will have been diagnosed in the United States alone. Prostate cancer is the second leading cause of

Method of treating prostate cancer with GnRH antagonist

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Prostate cancer is a leading cause of morbidity and mortality for men in the industrialized world. The American Cancer Society estimates that during 2007 about 218,890 new cases of prostate cancer will have been diagnosed in the United States alone. Prostate cancer is the second leading cause of

Indole derivatives useful as testosterone 5.alpha.-reductase inhibitors

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
This application is a National Stage application of PCT/JP94/00406, filed Mar. 14, 1994, which published as WO94/22821 on Oct. 13, 1994. TECHNICAL FIELD The present invention relates to novel indole derivatives and pharmaceutically acceptable salts thereof. More particularly, it relates to novel

Inhibitors for testosterone 5.alpha.-reductase activity

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION This invention relates to pharmaceutical compositions and methods for the treatment of androgen-related diseases, said compositions having novel inhibitors of testosterone 5.alpha.-reductase activity. The inhibitors have a good combination of inhibitory effect on

Testosterone compounds and use for the protection of neurons

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD The present invention relates to novel methods for conferring neuroprotection on a subject that relies on administering an effective dose of at least one testosterone inhibitor. BACKGROUND TO THE INVENTION Neurodegenerative diseases have a major impact on society. For example,
BACKGROUND OF THE INVENTION Prostate cancer is the most commonly diagnosed cancer in American men and the second most common cause of death from cancer in American men. Androgen withdrawal, by castration or through the use of an anti-androgenic drug, is the preferred treatment method for prostate

Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION This application relates to a method and compositions for chemosensitization and radiosensitization of cancer cells through administration of compositions, such as antisense oligonucleotides, which reduce the amount of TRPM-2 in the cells. The invention is of particular

Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION This application relates to a method and compositions for chemosensitization and radiosensitization of cancer cells through administration of compositions, such as antisense oligonucleotides, which reduce the amount of TRPM-2 in the cells. The invention is of particular

Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION This application relates to a method and compositions for chemosensitization and radiosensitization of cancer cells through administration of compositions, such as antisense oligonucleotides, which reduce the amount of TRPM-2 in the cells. The invention is of particular

Anti-aromatase pharmaceutical composition for controlling testosterone/estrone ratios

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
It is known, that throughout life of a mammal or a human being, testosterone/estrone ratios do have a considerable effect on mammal or human life. This testosterone/estrone ratio will exert a powerful and considerable reactions to the emotional well being, as well as in sexual functions, libido,
Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta znanošću

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti znanošću
  • Prepoznavanje bilja slikom
  • Interaktivna GPS karta - označite bilje na mjestu (uskoro)
  • Pročitajte znanstvene publikacije povezane s vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima

Google Play badgeApp Store badge